A guideline has been developed to improve accuracy in the testing of the expression status of estrogen and progesterone receptors. Medscape Medical News
The PARP inhibitor, olaparib, is showing promise not only in ovarian cancer associated with BRCA1 and BRCA2 mutations but also in ovarian cancer without these BRCA gene mutations. Medscape Medical News
Commentary on a pilot human study on the potential diagnostic utility of the combined administration of F-18-fluoride and F-18-FDG in a single PET-CT study for the detection of malignant lesions. Medscape Radiology
Watch and listen as Dr. Marshall Posner describes the most important findings in head and neck cancer to emerge from the 2009 annual ASCO conference. Medscape Hematology-Oncology